Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA?

A.A. Kayacelebi; V.V. Pham; J. Willers; Andreas Hahn; D.O. Stichtenoth; J. Jordan; D. Tsikas

doi:10.1016/j.ijcard.2014.07.296

Details

Originalsprache	Englisch
Seiten (von - bis)	1129-1131
Seitenumfang	3
Fachzeitschrift	International Journal of Cardiology
Jahrgang	176
Ausgabenummer	3
Publikationsstatus	Veröffentlicht - 20 Okt. 2014

ASJC Scopus Sachgebiete

Medizin (insg.)
Kardiologie und kardiovaskuläre Medizin

Ziele für nachhaltige Entwicklung

SDG 3 – Gute Gesundheit und Wohlergehen

Zitieren

Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA? / Kayacelebi, A.A.; Pham, V.V.; Willers, J. et al.
in: International Journal of Cardiology, Jahrgang 176, Nr. 3, 20.10.2014, S. 1129-1131.

Publikation: Beitrag in Fachzeitschrift › Artikel › Forschung › Peer-Review

Kayacelebi, AA, Pham, VV, Willers, J, Hahn, A, Stichtenoth, DO, Jordan, J & Tsikas, D 2014, 'Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA?', International Journal of Cardiology, Jg. 176, Nr. 3, S. 1129-1131. https://doi.org/10.1016/j.ijcard.2014.07.296

Kayacelebi, A. A., Pham, V. V., Willers, J., Hahn, A., Stichtenoth, D. O., Jordan, J., & Tsikas, D. (2014). Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA? International Journal of Cardiology, 176(3), 1129-1131. https://doi.org/10.1016/j.ijcard.2014.07.296

Kayacelebi AA, Pham VV, Willers J, Hahn A, Stichtenoth DO, Jordan J et al. Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA? International Journal of Cardiology. 2014 Okt 20;176(3):1129-1131. doi: 10.1016/j.ijcard.2014.07.296

Kayacelebi, A.A. ; Pham, V.V. ; Willers, J. et al. / Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA?. in: International Journal of Cardiology. 2014 ; Jahrgang 176, Nr. 3. S. 1129-1131.

Download

@article{8a535bfbf0f04aa8927e1d4069f1ab0d,

title = "Plasma homoarginine (hArg) and asymmetric dimethylarginine (ADMA) in patients with rheumatoid arthritis: Is homoarginine a cardiovascular corrective in rheumatoid arthritis, an anti-ADMA?",

keywords = "ADMA, Cardiovascular disease, Homoarginine, Rheumatoid arthritis",

author = "A.A. Kayacelebi and V.V. Pham and J. Willers and Andreas Hahn and D.O. Stichtenoth and J. Jordan and D. Tsikas",

year = "2014",

month = oct,

day = "20",

doi = "10.1016/j.ijcard.2014.07.296",

language = "English",

volume = "176",

pages = "1129--1131",

journal = "International Journal of Cardiology",

issn = "0167-5273",

publisher = "Elsevier Ireland Ltd",